Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
Rank in Stocks #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Share Price
$1.50
Last synced: 2026-09-21
Market Cap
$3.63M
Change (1 day)
-4.46%
Change (1 year)
-72.68%
Country
MY
Trade BioNexus Gene Lab Corp. (BGLC)

Category

P/E ratio for BioNexus Gene Lab Corp. (BGLC)
P/E ratio as of September 2026 TTM: -1.19
According to BioNexus Gene Lab Corp. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.19. At the end of 2023 the company had a P/E ratio of -3.47.
P/E ratio history for BioNexus Gene Lab Corp. from 2016 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) -1.19 -61.84%
2024 -3.12 -10.09%
2023 -3.47 -99.25%
2022 -461.48 -195.07%
2021 485.43 134.48%
2020 207.02 -126.84%
2019 -771.23 -113.97%
2018 5.52K -515.82%
2017 -1.33K -99.33%
2016 -196.70K 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
32.56 -2,834.67%
US
41.90 -3,619.39%
US
- -
US
22.99 -2,030.70%
US
- -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.